Thomas Mittag

Title: Thomas Mittag: Innovator in Glaucoma Treatment

Introduction

Thomas Mittag is a notable inventor based in Pleasantville, NY (US). He has made significant contributions to the field of ophthalmology, particularly in the treatment of glaucoma. His innovative approach focuses on reducing intraocular pressure, which is crucial for managing this eye condition.

Latest Patents

Thomas Mittag holds a patent for a method of reducing intraocular pressure and treating glaucoma. This invention involves administering a pharmaceutically acceptable salt isomeric to yohimbine and stereochemically similar to corynanthine topically to the eye. The method is designed to effectively reduce intraocular pressure in mammals, providing a potential therapeutic option for glaucoma patients. He has 1 patent to his name.

Career Highlights

Throughout his career, Thomas Mittag has demonstrated a commitment to advancing medical science. His work has focused on innovative solutions that address critical health issues, particularly in the realm of eye care. His dedication to research and development has positioned him as a valuable contributor to the field.

Collaborations

Thomas has collaborated with esteemed colleagues, including Janet B Serle and Steven D Podos. These partnerships have fostered an environment of innovation and have contributed to the success of his projects.

Conclusion

In summary, Thomas Mittag is a distinguished inventor whose work in glaucoma treatment showcases his innovative spirit and dedication to improving patient care. His contributions to the field are noteworthy and reflect his commitment to advancing medical science.